Cara Therapeutics (CARA) EBITDA US GAAP (year values)

2020 2021 2022 2023 2023   LTM ? CAGR 5 years ?
EBITDA, bln rub ? 5.59 -88.2 -83.8 -121.5 -117.7   -111.0  
Changes by years, y/y, % -105% -1 677% -5% +45% -3%     +8.7%

Cara Therapeutics. EBITDA US GAAP, bln rub

Cara Therapeutics. EBITDA US GAAP, changes, %

Cara Therapeutics. EBITDA US GAAP, sum by quarters, bln rub

Cara Therapeutics (CARA) EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2023Q4 2024Q1 2024Q2   LTM ?
EBITDA, bln rub ? -28.8 -32.6 -31.7 -28.7 -18.0   -111.0
Changes by years, y/y, % +21% +4% +1% +4% -42%    
Changes by quarters, q/q, % -7% +13% -3% -9% -37%    

Cara Therapeutics. EBITDA US GAAP, bln rub

Cara Therapeutics. EBITDA US GAAP, changes, y/y, %

Cara Therapeutics. EBITDA US GAAP, changes, q/q, %